A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
Clinical trial NCT06995820 · RECRUITING
Trial details
- NCT number
- NCT06995820
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-06
- Primary completion
- 2026-09-23
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.